BMEA(BMEA)
BMEA
ANALYST COVERAGE13 analysts
BUY
▲ +1286.9%upside to target
L $10.00
Med $19.00consensus
H $40.00Key MetricsTTM
Market Cap$81.51M
Revenue TTM$0.00
Net Income TTM-$44.95M
Free Cash Flow-$56.25M
Gross Margin0.0%
Operating Margin0.0%
Net Margin0.0%
Return on Equity-196.7%
Return on Assets-96.9%
Debt / Equity0.07
Current Ratio4.98
EPS TTM$-0.62
PRICE
Prev Close
1.33
Open
1.32
Day Range1.30 – 1.41
1.30
1.41
52W Range0.87 – 3.08
0.87
3.08
23% of range
VOLUME & SIZE
Avg Volume
1.5M
FUNDAMENTALS
P/E Ratio
-2.5x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
Beta
1.09
Market-like
TECHNICAL
RSI (14)
33
Bearish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 23
DEx-Dividend
In 90 days
Aug 20
PDividend Pay
In 131 days
Sep 30
BMEA News
About
No description available.
Industry
Research and Development in Biotechnology
Thorsten KirschbergExecutive Vice President of Research
Heow TanChief Technology & Quality Officer
Ramses ErdtmannCo-Founder, President, Chief Operating Officer & Director
Ravi UpasaniExecutive Vice President of Intellectual Property
Caroline Perez- DupontSenior Vice President of Contracts
Michael J. HitchcockInterim Chief Executive Officer & Director
Stephan MorrisChief Development Officer